|
---|
Category:Report
MONTHYEARML24282B0122024-10-29029 October 2024 NRC Report for September 2024 SRS Sdf Oov ML24213A0202024-10-21021 October 2024 Final Supporting Statement for 10 CFR Part 31 General Domestic Licenses for Byproduct Material (3150-0016) ML24289A0932024-10-0404 October 2024 ACMUI 2024 Bylaws Subcommittee Draft Report October 4, 2024 ML24274A1922024-09-30030 September 2024 GEH Vallecitos Boiling Water Reactor License Termination Plan Environmental Assessment ML24275A0752024-09-30030 September 2024 TLR-RES/DE/REB-2024-16, Integration of Safety, Security, and Safeguards During Design and Operations - a Technical Assessment and Regulatory Considerations for Advanced Reactor and Advanced Fuel Fabrication Facilities ML24270A1282024-09-26026 September 2024 Licensing Actions Received Month of March 2024 ML24256A1702024-09-19019 September 2024 Results of the NRCs Section 610 Review of the Physical Protection of Byproduct Material ML22035A0822024-08-23023 August 2024 SA-300 Handbook Comment Resolution - External ML24053A1032024-08-22022 August 2024 Final Rule ASME 2021-2022 Congressional Review Act Summary ML24221A1452024-08-0808 August 2024 ACMUI Subcommittee on Financial Assurance Draft Report, August 8 2024 ML24185A2682024-07-0303 July 2024 ACMUI Training and Experience (T&E) for All Modalities Subcommittee Final July 3, 2024 ML24214A3272024-04-30030 April 2024 Environmental Assessment and Finding of No Significant Impact for the Construction Permits for the Kairos Hermes 2 Test Reactors - Draft Report for Comment ML24120A2452024-04-24024 April 2024 ACMUI Spring 2024 Eye90 Subcommittee Final Report, Dated April 24 2024 ML24106A0982024-04-15015 April 2024 Advisory Committee on the Medical Uses of Isotopes (Acmui), Akesis Galaxy Rti Draft Licensing Guidance, Final Report, April 15, 2024 ML24116A2572024-03-16016 March 2024 Subcommittee on Yttrium-90 Microsphere Brachytherapy Eye90 Microspheres Device, Dated March 16 2024, Draft Report ML24018A1152024-01-19019 January 2024 Acu Msrr - Historic and Cultural Resources ML23338A2572023-12-14014 December 2023 Kairos Power LLC - Summary Record of Decision ML23333A0142023-11-27027 November 2023 Attachment F - Groundwater Tek Inc - Peer Review Study Final-1 ML23333A0172023-11-27027 November 2023 Attachment I - Chin - the Cooling Canal System at the FPL-Turkey-Point Power Station ML23229A2272023-11-0909 November 2023 Response to SRM-M230814 - Rulemaking - Final Rule - Comment Response Document - Emergency Preparedness for Small Modular Reactors and Other New Technologies ML22354A2652023-11-0808 November 2023 2. Proposed CoC No. 1026, Renewed Amendment No. 0 ML22354A2692023-11-0808 November 2023 6. Proposed CoC No. 1026, Renewed Amendment No. 1 ML23251A0462023-09-30030 September 2023 Technical Report - Review of Documents Related to Tank 12H Grout Formulations ML23194A1352023-09-0707 September 2023 OMB 3150-0007, Final Supporting Statement for 10 CFR Part 34, Licenses for Radiography and Radiation Safety Requirements for Radiographic Operations ML23192A7672023-08-21021 August 2023 Intercontinental Energy Corporation Final Completion Review Report Review and Approval ML22353A5992023-06-21021 June 2023 Enclosure - NMSS VLSSIR Wg Report and Implementation Guidance ML23097A1712023-05-0808 May 2023 Review of New and Potentially Significant Information for the Holtec Environmental Impact Statement for a Consolidated Interim Storage Facility for Spent Nuclear Fuel in Lea County, New Mexico ML22271A8622023-03-24024 March 2023 OMB-3150-0017 Final Supporting Statement for 10 CFR Part 30 Rules of General Applicability to Domestic Licensing of Byproduct Material ML22320A0752023-02-28028 February 2023 Draft Supporting Statement- Requests to Indian Tribes for Information (3150-0245) ML22318A1272023-01-0303 January 2023 Final OMB Supporting Statement: NRC Form 314 ML22133A0462022-11-10010 November 2022 Response to SRM-M220323: Final Rule-Backfitting and Issue Finality Assessment for Fitness for Duty Drug Testing Requirements ML22133A0522022-11-10010 November 2022 Response to SRM-M220323: Final Rule-Response to Public Comments for Fitness for Duty Drug Testing Requirements SECY-20-0109, Rulemaking: Regulatory Basis for Reporting Requirements for Nonemergency Events at Nuclear Power Plants Rulemaking2022-11-0404 November 2022 Rulemaking: Regulatory Basis for Reporting Requirements for Nonemergency Events at Nuclear Power Plants Rulemaking ML21267A0942022-09-30030 September 2022 Rulemaking: Final Rule: Comment Response Document: Incorporate by Reference American Society of Mechanical Engineers Boiler and Pressure Vessel Code and Operations and Maintenance Code ML21267A0982022-09-30030 September 2022 Rulemaking: Final Rule: Annotated Public Comments Document: Incorporate by Reference American Society of Mechanical Engineers Boiler and Pressure Vessel Code and Operations and Maintenance Code ML22117A2072022-08-16016 August 2022 OMB 3150-0120, Supporting Statement Draft for NRC Form 313 Application for Materials License, and NRC Forms 313A ML22201A5012022-07-26026 July 2022 U.S. Nuclear Regulatory Commission Sustainability Report and Implementation Plan 2022 ML22165A1662022-07-20020 July 2022 OMB 3150-0055, Final Supporting Statement for Title 10 of the Code of Federal Regulations Part 75 Safeguards on Nuclear Material - Implementation ML22130A1542022-07-0707 July 2022 Final OMB Supporting Statement for 10 CFR Part 150 Exemptions and Continued Regulatory Authority in Agreement States and Offshore Waters ML22178A0662022-05-24024 May 2022 SRMC-CWDA-2022-00006, Rev. 0, Fiscal Year 2022 Savannah River Site Liquid Waste Facilities Performance Assessment Maintenance Program ML22084A6102022-04-11011 April 2022 NRC Communication with American Board of Health Physics (Abhp) in 2019 Thru 2022 ML21196A1002022-03-0202 March 2022 Rulemaking: Final Rule: Comment Response Document American Society of Mechanical Engineers Code Cases RG 1.84, Rev 39; RG 1.147, Rev 20; and RG 1.192, Rev 4 ML22032A0012022-02-28028 February 2022 Rulemaking; Proposed Rule; Unofficial Redline Rule Language for the Proposed Rule - Regulatory Improvements for Production and Utilization Facilities Transitioning to Decommissioning ML22200A2692022-02-0202 February 2022 5Q1.2-302, Rev. 31, Proceduradiation Monitoring - Water Sampling Analysis ML22021B2992022-01-21021 January 2022 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on RG 8.39, Release of Patients Administered Radioactive Materials, Review and Comment on the Draft Civaderm Device Licensing Guidance, Final Report, January 21, 2022 ML21350A4522021-12-15015 December 2021 Enclosure - Materials RAI Response Clarifications ML21280A1032021-12-0606 December 2021 Updated Biological Assessment of Impacts to Federally Listed Species Under NMFS Jurisdiction for SONGS Decommissioning ML21341A5592021-12-0101 December 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on RG 8.39 Release of Patients Administered Radioactive Materials, Review and Comments on the Draft Civaderm Device Licensing Guidance, Draft Report, December 1, 2021 ML21341A5642021-12-0101 December 2021 Advisory Committee on the Medical Uses of Isotopes (Acmui), Subcommittee on RG 8.39 Release of Patients Administered Radioactive Materials, Review and Comment on Draft Proposed Revision 2 to Regulatory Guide 8.39, Draft Report, December 15, ML21341A5612021-11-29029 November 2021 Advisory Committee on the Medical Uses of Isotopes (Acmui), Subcommittee on Alpha Dart, Review and Comment on Draft Licensing Guidance Alpha Tau Alpha Dart Manual Brachytherapy, Draft Report, December 15, 2021 2024-09-30
[Table view]Some use of "" in your query was not closed by a matching "". Category:Technical
MONTHYEARML24274A1922024-09-30030 September 2024 GEH Vallecitos Boiling Water Reactor License Termination Plan Environmental Assessment ML24275A0752024-09-30030 September 2024 TLR-RES/DE/REB-2024-16, Integration of Safety, Security, and Safeguards During Design and Operations - a Technical Assessment and Regulatory Considerations for Advanced Reactor and Advanced Fuel Fabrication Facilities ML24256A1702024-09-19019 September 2024 Results of the NRCs Section 610 Review of the Physical Protection of Byproduct Material ML24214A3272024-04-30030 April 2024 Environmental Assessment and Finding of No Significant Impact for the Construction Permits for the Kairos Hermes 2 Test Reactors - Draft Report for Comment ML24120A2452024-04-24024 April 2024 ACMUI Spring 2024 Eye90 Subcommittee Final Report, Dated April 24 2024 ML24018A1152024-01-19019 January 2024 Acu Msrr - Historic and Cultural Resources ML23333A0142023-11-27027 November 2023 Attachment F - Groundwater Tek Inc - Peer Review Study Final-1 ML23333A0172023-11-27027 November 2023 Attachment I - Chin - the Cooling Canal System at the FPL-Turkey-Point Power Station ML22354A2652023-11-0808 November 2023 2. Proposed CoC No. 1026, Renewed Amendment No. 0 ML22354A2692023-11-0808 November 2023 6. Proposed CoC No. 1026, Renewed Amendment No. 1 ML23251A0462023-09-30030 September 2023 Technical Report - Review of Documents Related to Tank 12H Grout Formulations ML23192A7672023-08-21021 August 2023 Intercontinental Energy Corporation Final Completion Review Report Review and Approval ML22353A5992023-06-21021 June 2023 Enclosure - NMSS VLSSIR Wg Report and Implementation Guidance ML23097A1712023-05-0808 May 2023 Review of New and Potentially Significant Information for the Holtec Environmental Impact Statement for a Consolidated Interim Storage Facility for Spent Nuclear Fuel in Lea County, New Mexico ML22178A0662022-05-24024 May 2022 SRMC-CWDA-2022-00006, Rev. 0, Fiscal Year 2022 Savannah River Site Liquid Waste Facilities Performance Assessment Maintenance Program ML22021B2992022-01-21021 January 2022 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on RG 8.39, Release of Patients Administered Radioactive Materials, Review and Comment on the Draft Civaderm Device Licensing Guidance, Final Report, January 21, 2022 ML21280A1032021-12-0606 December 2021 Updated Biological Assessment of Impacts to Federally Listed Species Under NMFS Jurisdiction for SONGS Decommissioning ML21341A5592021-12-0101 December 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on RG 8.39 Release of Patients Administered Radioactive Materials, Review and Comments on the Draft Civaderm Device Licensing Guidance, Draft Report, December 1, 2021 ML21341A5642021-12-0101 December 2021 Advisory Committee on the Medical Uses of Isotopes (Acmui), Subcommittee on RG 8.39 Release of Patients Administered Radioactive Materials, Review and Comment on Draft Proposed Revision 2 to Regulatory Guide 8.39, Draft Report, December 15, ML21341A5612021-11-29029 November 2021 Advisory Committee on the Medical Uses of Isotopes (Acmui), Subcommittee on Alpha Dart, Review and Comment on Draft Licensing Guidance Alpha Tau Alpha Dart Manual Brachytherapy, Draft Report, December 15, 2021 ML21294A3422021-11-24024 November 2021 COVID-19 Public Health Emergency Oversight Activities Assessment Phase B Report ML21172A2822021-10-19019 October 2021 Physical Security Requirements for Category II Fuel Cycle Facilities Information Sheet (HALEU Related) ML21287A6312021-10-14014 October 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Emerging Radiopharmaceutical Therapy Knowledge Requirements in Theranostics Subcommittee, Final Report, October 14, 2021 ML21288A1262021-10-14014 October 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on Radionuclide Generator Knowledge and Practice Requirements, Final Report, October 14, 2021 ML22012A0702021-10-0404 October 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on Medical Events, Draft Report, October 4, 2021 ML22012A0652021-09-20020 September 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on Emerging Radiopharmaceutical Therapy Knowledge Requirements in Theranostics, Draft Report, September 20, 2021 ML22012A0672021-09-0808 September 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on Radionuclide Generator Knowledge and Practice Requirements, Draft Report, September 8, 2021 ML21232A5432021-08-20020 August 2021 Advanced Reactors Details Website ML21210A3512021-07-30030 July 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on Extravasations, Review and Comments on the Preliminary Evaluation of Radiopharmaceutical Extravasation and Medical Event Reporting, Draft Report, July 30, 2021 ML21085A7472021-04-30030 April 2021 Glwg Agreement State Survey Summary ML21144A1192021-04-0808 April 2021 RA-136-Reclassified ML21144A1202021-04-0808 April 2021 RA-432-Reclassified ML21144A1222021-04-0808 April 2021 SYP-233-Reclassified ML20133J9292020-05-18018 May 2020 Enclosure 1, Technical Evaluation Review of Decommissioning Funding Plan (Publicly Available) ML20128J8322020-05-11011 May 2020 Technical Evaluation Report for the Draft Wir Evaluation for Closure of Wma C at Hanford Site, Washington ML20079E0862020-03-0202 March 2020 Necr B8 Wb (002) ML20079E0892020-03-0202 March 2020 Reply to Arlt Comments 3-2-2020 Draft (002) ML20075A0292020-03-0202 March 2020 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Bylaws Subcommittee, Draft Report, March 2, 2020 ML19297E7912019-10-23023 October 2019 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on the Appropriateness of Medical Event Reporting, Final Report, October 23, 2019 ML19280D1632019-10-0606 October 2019 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Comments on the Draft Evaluation of Training & Experience Requirements for Radiopharmaceuticals Secy Paper, Draft Report, October 6, 2019 ML19297E6942019-08-28028 August 2019 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on the Appropriateness of Medical Event Reporting, Draft Report, August 28, 2019 ML19297E9022019-08-21021 August 2019 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on Medical Event Reporting, Review of FY2018, Draft Report, August 21, 2019 ML19296D1202019-08-0808 August 2019 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on ACMUI Institutional Memory, Draft Report, August 8, 2019 ML19106A3672019-07-25025 July 2019 Germanium-68/Gallium-68 Pharmaceutical Grade Generators Licensing Guidance ML19162A2592019-07-22022 July 2019 Technical Analyses of the Hazards of Disposal of Greater-Than-Class C (GTCC) Waste ML19198A2522019-06-20020 June 2019 Alternate Disposal Request - Rail Shipments (License DPR-28, Docket No. 50-271) ML18061A0502018-12-31031 December 2018 U.S. Nuclear Regulatory Commission Staff Responses to Public Comments on Proposed Rule: Amendments to Material Control and Accounting Regulations and Associated Draft Guidance ML18164A0712018-09-20020 September 2018 Us Ecology Idaho Site-Specific Dose Assessment Rev. 3 - TER (Public) ML18204A2142018-08-28028 August 2018 Enclosures 1-6: Pssc Multiple Closure ML18071A4132018-02-27027 February 2018 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Physical Presence Requirements for the Leksell Gamma Knife Icon, Final Report, February 27, 2018 2024-09-30
[Table view]Some use of "" in your query was not closed by a matching "". Category:Security Plan
MONTHYEARML21172A2822021-10-19019 October 2021 Physical Security Requirements for Category II Fuel Cycle Facilities Information Sheet (HALEU Related) ML20192A0432020-07-0202 July 2020 Attachment 2: ASM for Access Authorization and Fingerprinting at Independent Spent Fuel Storage Installation 2021-10-19
[Table view]Some use of "" in your query was not closed by a matching "". |
Text
PHYSICAL SECURITY REQUIREMENTS FOR FACILITIES WITH CATEGORY II QUANTITIES OF SPECIAL NUCLEAR MATERIAL INFORMATIONAL SHEET
Background
The purpose of these questions and answers (Q&As) is to provide clarity on the US Nuclear Regulatory Commission (NRC) staffs current regulatory approach for the physical security of special nuclear material (SNM) of moderate strategic significance as defined in Title 10 of the Code for Federal Regulations (10 CFR) Section 70.4 and 10 CFR 73.2 (also referred to as Category II quantity of SNM). High assay low enriched uranium (HALEU) is uranium enriched between 5% but less than 20% in U-235 isotope; facilities that possess U-235 that is enriched between 10% but less than 20% would fall under the Category II requirements in 10 CFR 73.67.
The NRC licensees such as fuel cycle facilities, non-power reactors and medical isotope facilities that plan to use, produce and handle HALEU as part of their proposed licensed activities may be subject to the requirements applicable to Category II quantities of SNM.
Additional public information on HALEU and certain licensing requests/actions can be found at Centrus Energy Corp Facility Licensing High Assay Low Enriched Uranium Demonstration webpage and at SHINE NRC Webpage.
Key Messages Protection of Category II quantities of SNM is regulated under 10 CFR 73.67.
Supplemental security measures for the protection of Category II quantities of SNM may be required to address the current threat environment and the changing understanding of the risks associated with facilities possessing Category II quantities of SNM.
Staff uses a risk-informed analysis on a case-by-case basis to develop appropriate site-specific supplemental security measures, if needed, that would be implemented through license conditions to ensure the security of Category II quantities of SNM.
Supplemental security requirements could include measures to provide greater security or control over material in use and storage and vital equipment; requirements for access controls (e.g., background checks), controlled access area (CAA) portals and vehicle access, escort requirements, random entry searches and exit searches, alarm stations, security patrols, communication and coordination with law enforcement, and implementation of a security equipment maintenance program.
To ensure a timely and efficient review, applicants planning to possess Category II quantities of SNM should engage with NRC staff early in the licensing process and should provide the facility setting, facility processes, types of materials (physical/chemical forms, enrichment, quantity), facility layout, and material flow (transportation, storage, use). The early establishment of an information security program allows for more detailed information to be shared expeditiously.
2 Q&As
- 1. What are the types of SNM that the NRC regulates?
There are three categories of SNM that the NRC regulates: Category I (i.e., formula quantity1of strategic SNM), Category II (i.e., SNM of moderate strategic significance2), or Category III (i.e., SNM of low strategic significance3). The SNM is categorized based on its type, quantity (i.e., mass), and enrichment for uranium-235. Strategic SNM consists of high enriched uranium, uranium-233, and plutonium. The regulations in 10 CFR Part 73 implement a risk-informed graded approach and identify requirements for the physical protection of SNM depending on the Category (i.e., the protection of Category I SNM is significantly greater than Category III SNM).
- 2. What types of facilities possess Category II quantities of SNM? How are these facilities related to advanced reactor fuels?
Category II facilities are licensed to possess SNM of moderate strategic significance as defined in 10 CFR 70.4 and 73.2. These facilities include HALEU fuel cycle facilities (e.g., uranium enrichment plants and fuel fabrication facilities), non-power reactors, and medical isotope facilities. HALEU fuel is required for most of the U.S. advanced reactors types to achieve smaller designs that produce more power per unit of volume.
- 3. Can a licensee possess some amount of high-enriched uranium (20% U-235 or greater) and still be considered a Category II facility?
Yes, the definition of Category II quantities of SNM includes possession of less than a formula quantity of strategic special nuclear material, but more than 1000 grams of U-235 contained in uranium enriched to 20% or more of U-235. The Category II physical security requirements apply to licensees that possess this limited amount of higher-enriched uranium.
- 4. What are the existing physical protection requirements and current regulatory approach for Category II quantities of SNM?
1 Formula quantity means strategic special nuclear material in any combination in a quantity of 5000 grams or more computed by the formula, grams = (grams contained U-235) + 2.5 (grams U-233 + grams plutonium). This class of material is sometimes referred to as a Category I quantity of material.
2 SNM of moderate strategic significance means less than a formula quantity of strategic special nuclear material but more than 1,000 grams of uranium-235 (contained in uranium enriched to 20 percent or more in the U-235 isotope) or more than 500 grams of uranium-233 or plutonium, or in a combined quantity of more than 1,000 grams when computed by the equation, grams = (grams contained U-235) + 2 (grams U-233 + grams plutonium); or 10,000 grams or more of uranium-235 (contained in uranium enriched to 10 percent or more but less than 20 percent in the U-235 isotope).
3SNM of low strategic significance means less than an amount of special nuclear material of moderate strategic significance as defined in paragraph (1) of the definition of strategic nuclear material of moderate strategic significance in this section, but more than 15 grams of uranium-235 (contained in uranium enriched to 20 percent or more in U-235 isotope) or 15 grams of uranium-233 or 15 grams of plutonium or the combination of 15 grams when computed by the equation, grams = (grams contained U-235) + (grams plutonium) + (grams U-233); or Less than 10,000 grams but more than 1,000 grams of uranium-235 (contained in uranium enriched to 10 percent or more but less than 20 percent in the U-235 isotope); or 10,000 grams or more of uranium-235 (contained in uranium enriched above natural but less than 10 percent in the U-235 isotope)
3 The existing physical security requirements for possession of and transport of Category II quantities of SNM are in 10 CFR 73.67. Regulatory Guide 5.59, Standard Format and Content for a Licensee Physical Security Plan for the Protection of Special Nuclear Material of Moderate or Low Strategic Significance, describes, in part, the information required in the physical security plan submitted as part of an application for a license to possess, use, or transport Category II quantities of SNM or 10 kg or more of Category III quantities of SNM and recommends a standard format for presenting the information in an orderly arrangement. These regulations and guidance address a wide variety of Category II facilities, taking into account the material being used, the purpose of the facility, and security aspects of specific sites. However, this flexibility may not obviate the need for specific supplemental measures at a given Category II facility.
The NRC staffs current regulatory approach considers the need for supplemental security measures in addition to the requirements in the existing regulations because the threat environment has changed and the risks associated with SNM are better understood than when the existing regulations were promulgated. Therefore, the NRC staff conducts case-specific reviews of physical security plans and includes site-specific supplemental security measures, as needed, as license conditions. The staff review relies on a risk-informed analysis to determine whether supplemental requirements are necessary and considers (1) the attractiveness of the material involved, and (2) the overall effectiveness of the applicants physical security plan. These supplemental measures are applied based on the specific threat environment and the risks associated with SNM. The general performance objectives in the existing regulations (10 CFR 73.67(a)), require in part, that a licensees physical protection system provide early detection and assessment of unauthorized access or activities by an external adversary within the CAA containing special nuclear material. In contrast, the supplemental measures aim to ensure that a licensee is able to promptly detect and assess attempts to remove special nuclear material. This change in detection and assessment timing, in part, drives the need for supplemental security measures.
Because of the range of potential Category II facilities, supplemental security measures would generally be site-specific and implemented through license conditions instead of generic orders. Facility-specific examples cannot be discussed due to the sensitive nature of the information; however, the staff is relying upon information in the regulatory basis document for rulemaking (Agencywide Documents Access and Management System (ADAMS) Accession No. ML18332A053) to inform its understanding of the types of supplemental security information that could potentially be applied to Category II facilities. Such supplemental security requirements could include measures to provide greater security or control over material in use and storage and vital equipment; requirements for access controls (e.g., background checks), controlled access area (CAA) portals and vehicle access, escort requirements, random entry searches and exit searches, alarm stations, security patrols, communication and coordination with law enforcement, and implementation of a security equipment maintenance program.
- 5. How will the NRC staff provide consistent and transparent Part 73 reviews?
Consistent with the NRCs Open Government Policy, all NRC reviews are conducted in a manner that is as open and transparent as possible, while still maintaining the necessary information security standards. As each application proceeds through the licensing
4 process, the staff will provide appropriate information to the public through public meetings, security evaluation reports, etc., when possible.
- 6. What information should an applicant be prepared to discuss to ensure productive discussions with NRC during early interactions (e.g., pre-application meetings)?
Consistent with the Advanced Reactor Policy Statement4, NRC encourages applicants to participate in early interactions with the NRC. In order for an applicant or licensee to effectively engage in the early interactions, they should be prepared to discuss the facility setting, facility processes, types of materials (physical/chemical forms, enrichment, quantity), facility layout, and material flow (transportation, storage, use).
Specific information can be found under the physical security requirements for Category II quantities of SNM in 10 CFR 73.67. The corresponding guidance for the development of a physical security plan in Regulatory Guide 5.59, Standard Format and Content for a Licensee Physical Security Plan for the Protection of Special Nuclear Material of Moderate or Low Strategic Significance, explains the intent of the provisions of 10 CFR 73.76 and discusses of each subsection provides for alternative ways to fulfill the requirements. Furthermore, the NRC follows its public meeting policy5 when engaging with applicants or licensees.
- 7. Has the NRC staff identified lessons learned during the recent SHINE and Centrus license reviews?
Lessons learned include: (1) early and frequent engagements among applicants, licensees and the NRC staff lead to more efficient reviews because site-specific information can be thoroughly discussed, (2) use of audits can aid in shared understanding of how an applicant will ensure adequate security design, and (3) the early establishment of an information security program allows for more detailed information to be shared expeditiously.
- 8. Is SECY-11-0184, Security Regulatory Framework for Certifying, Approving, and Licensing Small Modular Reactors," applicable for physical security requirements for fuel cycle facilities with Category II quantities of SNM?
No. SECY-11-0184 (ADAMS Accession No. ML112991113) validated the Category III (special nuclear material of low strategic significance) security requirements as being adequate for Small Modular Reactors. It did not validate Category II security requirements for Small Modular Reactors or any other facility with Category II quantities of SNM. Therefore, it is not applicable to HALEU Category II applicants.
- 9. Does the Physical Security for Advanced Reactors rulemaking include requirements for Category II SNM at facilities other than power reactors?
No. SECY-18-0076, Options and Recommendation for Physical Security for Advanced Reactors (ADAMS Accession No. ML18052B032), proposed a series of options to address a limited set of security alternatives for advanced reactors. In SRM SECY 0076, the Commission approved Option 3, a limited-scope rulemaking that retains the 4 Policy Statement on the Regulation of Advanced Reactors (73 FR 60612; October 14, 2008) 5 Policy Statement on Enhancing Participation in NRC Public Meetings (86 FR 14964; March 19, 2021)
5 current overall framework for security requirements but provides certain alternative security requirements for advanced reactors. The limited scope of the proposed rule, if approved by the Commission, will provide a set of alternative security requirements (i.e.,
armed responders, physical barriers, secondary alarm station, and vital areas) that qualified applicants or licensees may elect to implement instead of certain existing prescriptive requirements in 10 CFR 73.55. The Commission did not authorize a broader rulemaking for a new security framework for advanced reactors, and did not authorize any rulemaking to update the security requirements in 10 CFR 73.67 for the possession of Category II or Category III quantities of material. Currently, for a licensee to possess Category II quantities of material, the NRC addresses the needed security commensurate with the strategic significance of the SNM through regulations and license conditions to assure that activities involving SNM are not inimical to the common defense and security and do not constitute an unreasonable risk to the public health and safety.
- 10. Will the Part 53 rulemaking include new requirements for Category II quantities of SNM?
No. The current preliminary proposed rule text for Part 53, Risk Informed, Technology-Inclusive Regulatory Framework for Advanced Reactors, does not add new physical security requirements for Category II quantities of materials. The new rulemaking would adopt technology-inclusive approaches (approaches not specific to a single technology) and include the appropriate use of risk-informed and performance-based techniques, to provide the necessary flexibility for licensing and regulating a variety of advanced nuclear reactor technologies and designs.